Laura ButtafocoSenior Consultant & Founder at ProteaSpeaker
Profile
Laura’s areas of expertise include CMC strategy, technology transfer, process scale-up, validation, program management, GMP compliance and risk management.
Laura has spent nearly 20 years in the industry where she has contributed to both small and large molecule projects. Acting as the main point of technical contact, as well as project/program manager, she has been responsible for completion of technology transfer and exhibit batches production in cooperation with various CMOs in EU, India and China.
Currently she operates as independent consultant for Protea, her own company. In this role, she has a proven track record of successfully closed large Capex assignments on behalf of medium as well as large and well-established pharmaceutical companies. She has worked on a variety of therapeutics, especially vaccines, including an approved COVID vaccine.
Agenda Sessions
The Tech Transfer Landscape for Bioprocessing
, 9:00amView SessionTech Transfer for Novel Modalities: Strategies for Success
, 11:00amView SessionEnsuring Seamless Tech Transfer: Best Practices and Strategies
, 1:00pmView SessionDigital Transformation in Tech Transfer: Leveraging Technology for Success
, 3:00pmView Session